Abeona Therapeutics Inc.
ABEO
$5.75
-$0.15-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 0.00 | 3.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 0.00 | 3.50M |
| Cost of Revenue | 43.96M | 41.22M | 38.26M | 38.15M | 39.72M |
| Gross Profit | -43.96M | -41.22M | -38.26M | -38.15M | -36.22M |
| SG&A Expenses | 32.51M | 29.85M | 28.00M | 25.76M | 22.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.61M | 64.21M | 60.75M | 56.74M | 53.99M |
| Operating Income | -69.61M | -64.21M | -60.75M | -56.74M | -50.49M |
| Income Before Tax | -44.19M | -63.73M | -71.03M | -52.60M | -76.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -44.19 | -63.73 | -71.03 | -52.60 | -76.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.19M | -63.73M | -71.03M | -52.60M | -76.66M |
| EBIT | -69.61M | -64.21M | -60.75M | -56.74M | -50.49M |
| EBITDA | -67.56M | -62.21M | -58.79M | -54.75M | -48.37M |
| EPS Basic | -0.88 | -1.79 | -2.25 | -2.09 | -3.20 |
| Normalized Basic EPS | -0.55 | -1.12 | -1.40 | -1.31 | -2.04 |
| EPS Diluted | -1.32 | -2.24 | -2.69 | -2.54 | -3.20 |
| Normalized Diluted EPS | -0.57 | -1.14 | -1.43 | -1.33 | -2.04 |
| Average Basic Shares Outstanding | 186.55M | 164.09M | 141.10M | 117.82M | 95.83M |
| Average Diluted Shares Outstanding | 197.77M | 175.30M | 152.32M | 129.03M | 95.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |